ARTICLE | Financial News
Orexigen planning follow-on
October 25, 2012 12:29 AM UTC
Orexigen Therapeutics Inc. (NASDAQ:OREX) said late Wednesday it is planning a follow-on underwritten by Credit Suisse; BofA Merrill Lynch; and Leerink. Orexigen is evaluating the cardiovascular outcom...